Treating glioblastoma often makes a MES

Stead, L.F. orcid.org/0000-0002-9550-4150 (2022) Treating glioblastoma often makes a MES. Nature Cancer, 3 (12). pp. 1446-1448. ISSN 2662-1347

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: This version of the article has been accepted for publication, after peer review (when applicable) and is subject to Springer Nature’s AM terms of use (https://www.springernature.com/gp/open-research/policies/accepted-manuscript-terms), but is not the Version of Record and does not reflect post-acceptance improvements, or any corrections. The Version of Record is available online at: https://doi.org/10.1038/s43018-022-00471-1
Dates:
  • Published (online): 20 December 2022
  • Published: 20 December 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Molecular Medicine
Depositing User: Symplectic Publications
Date Deposited: 04 Jan 2024 17:05
Last Modified: 04 Jan 2024 17:06
Published Version: https://www.nature.com/articles/s43018-022-00471-1
Status: Published
Publisher: Springer
Identification Number: https://doi.org/10.1038/s43018-022-00471-1
Related URLs:

Export

Statistics